Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
about
Metabolite profiling of Alzheimer's disease cerebrospinal fluidA proteomic approach for the diagnosis of bacterial meningitisDecreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer's DiseasePlasma proteomics for the identification of Alzheimer disease.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.Cerebrospinal fluid analysis for diagnosis of noninflammatory, dementive and psychiatric diseases.Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.[German consortium for frontotemporal lobar degeneration].Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
P2860
Q28480903-3C599C07-2C03-4C52-8665-3C78136800ABQ33553299-4003CAEA-ADE7-4821-8AE5-54E84387E9B1Q33847248-8799585C-3EE6-48AF-A98F-457CD14AA6AAQ34123736-A3085B5C-7235-443B-9525-690A2C319586Q34155662-1BBAC30C-BEFC-4C68-A91E-F5CCF62D35BEQ36322982-ED87F08F-850D-41A0-8D56-D0A09A5B75F4Q36767124-8891EBB9-2841-423A-9434-BA91F4912F47Q37358672-021B896B-7A32-4BBF-8692-D65888971AB1Q37693146-50C6FEAB-211F-48F2-A615-DEA9D13EFC10Q38266699-EE0E4F77-E1B9-4A36-840C-FF4617093B76Q39207637-E34DBE38-739C-4E1B-95C4-7366E63D8091Q39319453-85FA091F-3F73-452B-8FC3-F2BB0783895CQ51065265-2066BA5F-0CC5-4F35-B974-B7C8365E33DBQ54058844-1BDDC5FC-921F-4656-B2B3-A768F21224A8Q57750814-5014C948-F9C2-4DFE-A20A-56F34010D8AC
P2860
Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neurochemical approaches of ce ...... in neurodegenerative diseases.
@en
Neurochemical approaches of ce ...... in neurodegenerative diseases.
@nl
type
label
Neurochemical approaches of ce ...... in neurodegenerative diseases.
@en
Neurochemical approaches of ce ...... in neurodegenerative diseases.
@nl
prefLabel
Neurochemical approaches of ce ...... in neurodegenerative diseases.
@en
Neurochemical approaches of ce ...... in neurodegenerative diseases.
@nl
P1433
P1476
Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases
@en
P2093
Markus Otto
Piotr Lewczuk
P304
P356
10.1016/J.YMETH.2007.06.012
P577
2008-04-01T00:00:00Z